Want to join the conversation?
Biotech products company $TMO said it agrees with $AFFX that the unsolicited, non-binding proposal $AFFX received from Origin Technologies could not be expected to lead to a superior proposal as defined in the merger plan between $TMO and AFFX. $TMO believes that its merger with $AFFX is in the best interest of both $AFFX and its stockholders.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th